Skip to content

Early Infectious Disease Consultations in Staphylococcus Aureus Bacteremia

Early Infectious Disease Consultation for Better Outcomes From Staphylococcus Aureus Bacteremia

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00622882
Enrollment
200
Registered
2008-02-25
Start date
2007-10-31
Completion date
2015-12-31
Last updated
2014-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Staphylococcus Aureus Bacteremia

Keywords

Staphylococcus aureus, Bacteremia, Outcome, Mortality, Recurrence, Infectious Diseases specialists

Brief summary

The primary objective is to determine if early infectious disease (ID) consultation (defined as within 48 hours of a positive blood culture) will reduce mortality rates from Staphylococcus aureus bacteremia (SAB). This study will also determine if such consultations could reduce the duration of hospitalisation, recurrence and financial costs in patients with this infection.

Detailed description

Bacteremia is a serious manifestation of Staphylococcus aureus infection with an attributable mortality as high as 25% in MRSA bacteremia. More than a third of patients end up with complications such as endocarditis, osteomyelitis or pneumonia. Overall the outcome of patients with respect to mortality or recurrence is better in patients who have an eradicable focus and have received an appropriate antibiotic dose and duration. Also complicated bacteremia is more common in patients with * persistent bacteremia or fever * prosthetic device * new murmur * skin findings of a systemic infection Based on this evidence, an ID consultation could improve the outcomes of patients with SAB by * Advising adequate antibiotic dosage and duration * Sourcing out and counselling eradication of any focus of infection

Interventions

OTHERinfectious disease specialist consultation

Randomised trial to determine the utility of an early Infectious disease Consultation in Staphylococcus aureus bacteremic patients ( in the first 48 hours of a positive blood culture)

Sponsors

National University Hospital, Singapore
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Months to No maximum
Healthy volunteers
No

Inclusion criteria

* All inpatients at the National University Hospital with Staphylococcus aureus (both methicillin sensitive and methicillin resistant) bacteremia isolated within the defined time period

Exclusion criteria

* Patients who died or were discharged before the notification from the laboratory * Neonates * Polymicrobial bacteremia

Design outcomes

Primary

MeasureTime frame
mortality1 year

Secondary

MeasureTime frame
recurrence2 year
duration of hospitalisation1 year
financial costs of hospitalisation1 year

Countries

Singapore

Contacts

Primary ContactPaul A Tambyah, MD
mdcpat@nus.edu.sg(65)67724375

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026